ArticlePediatric cardiology2017
Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension.
Martin Koestenberger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2017
this papercites it